Women’s Health Bulletin

Published by: Kowsar

Assessment of Kidney Function and 24-Hour Urine of the Patients with Renal Stone; Women Have Lower Urine Volume and Higher Urine Citrate

Maryam Pakfetrat 1 , Leila Malekmakan ORCID 1 , * , Taraneh Tadayon 1 , Amin Nikfar 1 and Afshin Mansourian 2
Authors Information
1 Shiraz Nephro-Urology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
2 Department of Anesthesiology, Yasuj University of Medical Sciences, Yasuj, Iran
Article information
  • Women’s Health Bulletin: January 1, 2019, 6 (1); e88048
  • Published Online: February 20, 2019
  • Article Type: Research Article
  • Received: December 22, 2018
  • Revised: February 6, 2019
  • Accepted: February 14, 2019
  • DOI: 10.5812/whb.88048

How to Cite: Pakfetrat M, Malekmakan L, Tadayon T, Nikfar A , Mansourian A. Assessment of Kidney Function and 24-Hour Urine of the Patients with Renal Stone; Women Have Lower Urine Volume and Higher Urine Citrate, Women Health Bull. 2019 ; 6(1):e88048. doi: 10.5812/whb.88048.

Copyright © 2019, Women’s Health Bulletin. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Litwin MS, Saigal CS, Yano EM, Avila C, Geschwind SA, Hanley JM, et al. Urologic diseases in America project: Analytical methods and principal findings. J Urol. 2005;173(3):933-7. doi: 10.1097/01.ju.0000152365.43125.3b. [PubMed: 15711342].
  • 2. Knoll T. Epidemiology, pathogenesis, and pathophysiology of urolithiasis. Eur Urol Suppl. 2010;9(12):802-6. doi: 10.1016/j.eursup.2010.11.006.
  • 3. Bartoletti R, Cai T, Mondaini N, Melone F, Travaglini F, Carini M, et al. Epidemiology and risk factors in urolithiasis. Urol Int. 2007;79 Suppl 1:3-7. doi: 10.1159/000104434. [PubMed: 17726345].
  • 4. Raheem OA, Khandwala YS, Sur RL, Ghani KR, Denstedt JD. Burden of urolithiasis: Trends in prevalence, treatments, and costs. Eur Urol Focus. 2017;3(1):18-26. doi: 10.1016/j.euf.2017.04.001. [PubMed: 28720363].
  • 5. Safarinejad MR. Adult urolithiasis in a population-based study in Iran: Prevalence, incidence, and associated risk factors. Urol Res. 2007;35(2):73-82. doi: 10.1007/s00240-007-0084-6. [PubMed: 17361397].
  • 6. Bensalah K, Tuncel A, Gupta A, Raman JD, Pearle MS, Lotan Y. Determinants of quality of life for patients with kidney stones. J Urol. 2008;179(6):2238-43. discussion 2243. doi: 10.1016/j.juro.2008.01.116. [PubMed: 18423704].
  • 7. Malekmakan L, Haghpanah S, Pakfetrat M, Malekmakan A, Khajehdehi P. Causes of chronic renal failure among Iranian hemodialysis patients. Saudi J Kidney Dis Transpl. 2009;20(3):501-4. [PubMed: 19414964].
  • 8. Bagga HS, Chi T, Miller J, Stoller ML. New insights into the pathogenesis of renal calculi. Urol Clin North Am. 2013;40(1):1-12. doi: 10.1016/j.ucl.2012.09.006. [PubMed: 23177630]. [PubMed Central: PMC4165395].
  • 9. Ramaswamy K, Shah O. Metabolic syndrome and nephrolithiasis. Transl Androl Urol. 2014;3(3):285-95. doi: 10.3978/j.issn.2223-4683.2014.06.03. [PubMed: 26816779]. [PubMed Central: PMC4708567].
  • 10. Kasper DL, Harrison TR. Harrison's principles of internal medicine. New york: Mcgraw-Hill Medical; 2012.
  • 11. Spivacow FR, Negri AL, del Valle EE, Calvino I, Zanchetta JR. Clinical and metabolic risk factor evaluation in young adults with kidney stones. Int Urol Nephrol. 2010;42(2):471-5. doi: 10.1007/s11255-009-9623-0. [PubMed: 19653114].
  • 12. Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Twenty-four-hour urine chemistries and the risk of kidney stones among women and men. Kidney Int. 2001;59(6):2290-8. doi: 10.1046/j.1523-1755.2001.00746.x. [PubMed: 11380833].
  • 13. Perrier ET, Buendia-Jimenez I, Vecchio M, Armstrong LE, Tack I, Klein A. Twenty-four-hour urine osmolality as a physiological index of adequate water intake. Dis Markers. 2015;2015:231063. doi: 10.1155/2015/231063. [PubMed: 25866433]. [PubMed Central: PMC4381985].
  • 14. Moe OW. Kidney stones: Pathophysiology and medical management. Lancet. 2006;367(9507):333-44. doi: 10.1016/S0140-6736(06)68071-9. [PubMed: 16443041].
  • 15. Hosseini MM, Eshraghian A, Dehghanian I, Irani D, Amini M. Metabolic abnormalities in patients with nephrolithiasis: Comparison of first-episode with recurrent cases in Southern Iran. Int Urol Nephrol. 2010;42(1):127-31. doi: 10.1007/s11255-009-9599-9. [PubMed: 19548107].
  • 16. Nouri-Majalan N, Baghianimoghadam B, Amiri N, Moghaddasi-Moosavi S. Metabolic abnormalities in patients with recurrent stone formation in a hot territory. Bratisl Lek Listy. 2010;111(2):79-82. [PubMed: 20429319].
  • 17. Gault MH, Chafe L. Relationship of frequency, age, sex, stone weight and composition in 15,624 stones: Comparison of resutls for 1980 to 1983 and 1995 to 1998. J Urol. 2000;164(2):302-7. doi: 10.1016/S0022-5347(05)67345-4. [PubMed: 10893570].
  • 18. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. Family history and risk of kidney stones. J Am Soc Nephrol. 1997;8(10):1568-73. [PubMed: 9335385].
  • 19. Ljunghall S, Danielson BG, Fellstrom B, Holmgren K, Johansson G, Wikstrom B. Family history of renal stones in recurrent stone patients. Br J Urol. 1985;57(4):370-4. doi: 10.1111/j.1464-410X.1985.tb06290.x. [PubMed: 4027504].
  • 20. Pearle MS, Calhoun EA, Curhan GC, Urologic Diseases of America P. Urologic diseases in America project: Urolithiasis. J Urol. 2005;173(3):848-57. doi: 10.1097/01.ju.0000152082.14384.d7. [PubMed: 15711292].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments